Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,430 | -11,880 | -45,710 | -32,540 | -22,670 |
| Depreciation Amortization | 1,520 | 790 | 3,310 | 2,530 | 1,730 |
| Other Working Capital | -5,030 | -2,140 | -2,500 | -2,280 | -1,240 |
| Other Operating Activity | 6,590 | 4,890 | 9,410 | 5,290 | 3,390 |
| Operating Cash Flow | $-15,350 | $-8,340 | $-35,490 | $-27,000 | $-18,790 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 40 | 40 | 90 | 70 | 6 |
| Other Investing Activity | 8,110 | 1,530 | 1,070 | 7,590 | -2,576 |
| Investing Cash Flow | $8,150 | $1,570 | $1,160 | $7,660 | $-2,570 |
| Cash Flows From Financing Activities | |||||
| Dividend Paid | -90 | 0 | -500 | -250 | -250 |
| Other Financing Activity | 1,550 | 3,400 | 6,620 | -5,510 | -3,920 |
| Financing Cash Flow | $1,460 | $3,400 | $6,120 | $-5,760 | $-4,170 |
| Beginning Cash Position | 15,930 | 15,930 | 44,140 | 44,140 | 44,140 |
| End Cash Position | 10,200 | 12,570 | 15,930 | 19,040 | 18,600 |
| Net Cash Flow | $-5,730 | $-3,360 | $-28,200 | $-25,100 | $-25,540 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,350 | -8,340 | -35,490 | -27,000 | -18,790 |
| Free Cash Flow | -15,350 | -8,340 | -35,490 | -27,000 | -18,790 |